Eam Global Investors LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Eam Global Investors LLC

  • $402 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$99.73 - $148.48 $1.21 Million - $1.8 Million
-12,137 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$98.85 - $138.91 $1.2 Million - $1.69 Million
12,137 New
12,137 $1.69 Million
Q3 2019

Nov 13, 2019
SELL
$37.38 - $49.47 $1.58 Million - $2.09 Million
-42,238 Closed
0 $0
Q1 2019

May 10, 2019
BUY
$34.52 - $53.29 $1.46 Million - $2.25 Million
42,238 New
42,238 $2.17 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email